Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Saeed Shaaban"'
Autor:
Marwa Sayed Abdel-Tawab, Hanan Fouad, Doaa Mahmoud Khalil, Saeed Shaaban, Shaymaa Nafady, Hanan Hosni Moawad, Heba Ahmed Mostafa, Soha Mahmoud Abdel-Salam, Naglaa Adly Abd Elazeem, Alaa A. Mohamed
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background Hepatocellular carcinoma (HCC) is a common, serious malignancy with a dismal prognosis. As HCC is frequently missed in its early stages, non-invasive early detection is urgently needed. The purpose of this study was to evaluate th
Externí odkaz:
https://doaj.org/article/cbdb2bb201f1458eba2b1faab00cdcc5
Autor:
Marwa Sayed Abdel-Tawab, Hanan Fouad, Ahmed Yahiya, Ahmed Abd-Eltawab Tammam, Alzhraa M. Fahmy, Saeed Shaaban, Soha Mahmoud Abdel-Salam, Naglaa Adly Abd Elazeem
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 11, Iss 1, Pp 1-9 (2022)
Abstract Background Gastric carcinoma (GC) is a fatal disease. Detection of new biomarkers that can be utilized in the early diagnosis of GC is a pressing need. This present study assessed centrosomal protein-55 (CEP55)’ serpin family E member 1 (S
Externí odkaz:
https://doaj.org/article/c45e10506352448e8ce1a2ab74f350d0
Autor:
Marwa Sayed Abdel-Tawab, Hanan Fouad, Ahmed Yehia Ismaeel, Ahmed Abd-Eltawab Tammam, Alzhraa M. Fahmy, Saeed Shaaban, Soha Mahmoud Abdel-Salam, Naglaa Adly Abd Elazeem
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 12, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/fa5c5967dd6a4cb6b46d11ec28e96347
Autor:
Saeed Shaaban, Sarah Hamdy
Publikováno v:
International Journal of Cancer and Biomedical Research. 7:15-19
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:QIM23-134
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Objective Neoadjuvant concomitant chemoradiotherapy followed by surgical resection is the standard of care in the treatment of rectal cancer. We are investigating the value of adding combination chemotherapy oxaliplatin, irinotecan, leucovorin and fl